OTCMKTS:MJNA

Medical Marijuana Competitors

$0.06
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.05
Now: $0.06
$0.06
50-Day Range
$0.05
MA: $0.06
$0.09
52-Week Range
$0.01
Now: $0.06
$0.22
Volume7.76 million shs
Average Volume56.25 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Medical Marijuana (OTCMKTS:MJNA) Vs. IIPR, GRWG, XXII, KSHB, NSAV, and TRTC

Should you be buying MJNA stock or one of its competitors? Companies in the sub-industry of "cannabis" are considered alternatives and competitors to Medical Marijuana, including Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), 22nd Century Group (XXII), KushCo (KSHB), NSAV (NSAV), and Terra Tech (TRTC).

Innovative Industrial Properties (NYSE:IIPR) and Medical Marijuana (OTCMKTS:MJNA) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

Institutional and Insider Ownership

74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Innovative Industrial Properties and Medical Marijuana's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Industrial Properties$44.67 million101.23$23.48 million$3.2757.80
Medical MarijuanaN/AN/AN/AN/AN/A

Innovative Industrial Properties has higher revenue and earnings than Medical Marijuana.

Analyst Ratings

This is a breakdown of current ratings for Innovative Industrial Properties and Medical Marijuana, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Innovative Industrial Properties02502.71
Medical Marijuana0000N/A

Innovative Industrial Properties presently has a consensus price target of $192.4286, suggesting a potential upside of 1.82%. Given Innovative Industrial Properties' higher possible upside, equities research analysts clearly believe Innovative Industrial Properties is more favorable than Medical Marijuana.

Profitability

This table compares Innovative Industrial Properties and Medical Marijuana's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Innovative Industrial Properties55.71%6.05%4.82%
Medical MarijuanaN/AN/AN/A

Summary

Innovative Industrial Properties beats Medical Marijuana on 8 of the 8 factors compared between the two stocks.

Medical Marijuana (OTCMKTS:MJNA) and GrowGeneration (NASDAQ:GRWG) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends.

Profitability

This table compares Medical Marijuana and GrowGeneration's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medical MarijuanaN/AN/AN/A
GrowGeneration2.14%4.68%3.53%

Insider & Institutional Ownership

51.3% of GrowGeneration shares are held by institutional investors. 13.6% of GrowGeneration shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Medical Marijuana and GrowGeneration's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medical MarijuanaN/AN/AN/AN/AN/A
GrowGeneration$79 million39.97$1.88 million$0.10540.20

GrowGeneration has higher revenue and earnings than Medical Marijuana.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Medical Marijuana and GrowGeneration, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medical Marijuana0000N/A
GrowGeneration03502.63

GrowGeneration has a consensus target price of $49.5714, suggesting a potential downside of 8.24%. Given GrowGeneration's higher possible upside, analysts plainly believe GrowGeneration is more favorable than Medical Marijuana.

Summary

GrowGeneration beats Medical Marijuana on 8 of the 8 factors compared between the two stocks.

Medical Marijuana (OTCMKTS:MJNA) and 22nd Century Group (NYSEAMERICAN:XXII) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, valuation and risk.

Analyst Ratings

This is a summary of recent ratings and price targets for Medical Marijuana and 22nd Century Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medical Marijuana0000N/A
22nd Century Group00103.00

Profitability

This table compares Medical Marijuana and 22nd Century Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medical MarijuanaN/AN/AN/A
22nd Century GroupN/AN/AN/A

Valuation and Earnings

This table compares Medical Marijuana and 22nd Century Group's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medical MarijuanaN/AN/AN/AN/AN/A
22nd Century GroupN/AN/AN/AN/AN/A

Summary

22nd Century Group beats Medical Marijuana on 1 of the 1 factors compared between the two stocks.

KushCo (OTCMKTS:KSHB) and Medical Marijuana (OTCMKTS:MJNA) are both multi-sector conglomerates companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Earnings & Valuation

This table compares KushCo and Medical Marijuana's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KushCo$113.84 million1.80$-77,660,000.00($0.68)-1.90
Medical MarijuanaN/AN/AN/AN/AN/A

Medical Marijuana has lower revenue, but higher earnings than KushCo.

Profitability

This table compares KushCo and Medical Marijuana's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
KushCo-65.89%-47.95%-31.39%
Medical MarijuanaN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for KushCo and Medical Marijuana, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
KushCo01302.75
Medical Marijuana0000N/A

KushCo currently has a consensus target price of $1.8750, suggesting a potential upside of 45.35%. Given KushCo's higher possible upside, research analysts clearly believe KushCo is more favorable than Medical Marijuana.

Institutional and Insider Ownership

0.0% of KushCo shares are held by institutional investors. 17.3% of KushCo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

KushCo beats Medical Marijuana on 5 of the 8 factors compared between the two stocks.

Medical Marijuana (OTCMKTS:MJNA) and NSAV (OTCMKTS:NSAV) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability and earnings.

Earnings & Valuation

This table compares Medical Marijuana and NSAV's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medical MarijuanaN/AN/AN/AN/AN/A
NSAVN/AN/AN/AN/AN/A

Profitability

This table compares Medical Marijuana and NSAV's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medical MarijuanaN/AN/AN/A
NSAVN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Medical Marijuana and NSAV, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medical Marijuana0000N/A
NSAV0000N/A

Medical Marijuana (OTCMKTS:MJNA) and Terra Tech (OTCMKTS:TRTC) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability and earnings.

Earnings & Valuation

This table compares Medical Marijuana and Terra Tech's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medical MarijuanaN/AN/AN/AN/AN/A
Terra Tech$28.05 million2.25$-46,930,000.00N/AN/A

Medical Marijuana has higher earnings, but lower revenue than Terra Tech.

Profitability

This table compares Medical Marijuana and Terra Tech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medical MarijuanaN/AN/AN/A
Terra Tech-261.88%-110.38%-62.41%

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Medical Marijuana and Terra Tech, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medical Marijuana0000N/A
Terra Tech0000N/A

Insider and Institutional Ownership

0.1% of Terra Tech shares are owned by institutional investors. 6.7% of Terra Tech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.


Medical Marijuana Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Innovative Industrial Properties logo
IIPR
Innovative Industrial Properties
1.8$188.99flat$4.52 billion$44.67 million61.16
GrowGeneration logo
GRWG
GrowGeneration
1.7$54.02flat$3.16 billion$79 million1,080.62Analyst Revision
22nd Century Group logo
XXII
22nd Century Group
0.9$3.61flat$550.16 millionN/A0.00
KushCo logo
KSHB
KushCo
1.3$1.29flat$204.89 million$113.84 million-2.15Earnings Announcement
News Coverage
Gap Up
NSAV
NSAV
0.3$0.02flat$129.95 millionN/A0.00News Coverage
Gap Down
Terra Tech logo
TRTC
Terra Tech
0.7$0.29flat$63.02 million$28.05 million0.00News Coverage
General Cannabis logo
CANN
General Cannabis
0.6$0.89flat$55.31 million$3.67 million0.00
PVSP
Pervasip
0.4$0.01flat$45.10 millionN/A0.00Gap Up
Grow Capital logo
GRWC
Grow Capital
0.6$1.13flat$28.07 million$2.37 million0.00News Coverage
Gap Up
NMUS
Nemus Bioscience
0.6$0.12flat$16.07 millionN/A0.00High Trading Volume
Leafbuyer Technologies logo
LBUY
Leafbuyer Technologies
0.5$0.16flat$13.70 million$2.53 million0.00Gap Down
MassRoots logo
MSRT
MassRoots
0.6$0.02flat$11.16 million$20,000.000.00Gap Up
Peak Pharmaceuticals logo
PKPH
Peak Pharmaceuticals
0.7$0.14flat$10.59 millionN/A0.00News Coverage
Mentor Capital logo
MNTR
Mentor Capital
0.5$0.16flat$3.83 million$4.33 million-3.99
FutureWorld logo
FWDG
FutureWorld
0.5$0.00flat$3.80 millionN/A0.00Gap Up
DIGP
DigiPath
0.5$0.05flat$3.35 million$2.55 million-1.66Gap Up
NGBL
Notis Global
0.5$0.00flat$2.50 millionN/A0.00Gap Up
United Cannabis logo
CNAB
United Cannabis
0.4$0.02flat$1.70 millionN/A0.00
CrowdGather logo
CRWG
CrowdGather
0.7$0.01flat$1.68 million$160,000.000.00News Coverage
Gap Up
OPMZ
1PM Industries
0.4$0.00flat$0.00N/A0.00
AQSP
Acquired Sales
0.4$7.70flat$0.00N/A0.00
AMMJ
American Cannabis
0.5$0.23flat$0.00N/A0.00Gap Up
AmeriCann logo
ACAN
AmeriCann
0.4$1.21flat$0.00N/A0.00Gap Down
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.25flat$0.00N/A0.00
Cannabis Sativa logo
CBDS
Cannabis Sativa
0.5$0.78flat$0.00N/A0.00Gap Up
FRLF
Freedom Leaf
0.5$0.01flat$0.00N/A0.00Gap Up
FUTL
FutureLand
0.4$0.00flat$0.00N/A0.00News Coverage
Gap Up
GB Sciences logo
GBLX
GB Sciences
0.5$0.06flat$0.00N/A0.00News Coverage
Gap Down
GreenGro Technologies logo
GRNH
GreenGro Technologies
0.6$0.02flat$0.00N/A0.00Gap Down
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$3.06flat$0.00N/A0.00
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01flat$0.00N/A0.00News Coverage
Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00flat$0.00N/A0.00Gap Up
MDCL
Medicine Man Technologies
0.5$2.22flat$0.00N/A0.00
NCAP
Northsight Capital
0.5$0.00flat$0.00N/A0.00
OWC Pharmaceutical Research logo
OWCP
OWC Pharmaceutical Research
0.6$0.01flat$0.00N/A0.00Gap Up
Surna logo
SRNA
Surna
0.6$0.07flat$0.00N/A0.00
Ultrack Systems logo
MJLB
Ultrack Systems
0.6$0.09flat$0.00N/A0.00Gap Down
BUDZ
WEED
0.6$0.59flat$0.00N/A0.00Gap Up
Zoned Properties logo
ZDPY
Zoned Properties
0.6$0.65flat$0.00N/A0.00Gap Up
ZZLL
ZZLL Information Technology
0.4$0.32flat$0.00N/A0.00High Trading Volume
Gap Down
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.